Trending News
-
Market Movers
Gold Surges Amid Tariff Uncertainty and Market Reactions
Gold futures experienced a massive surge on Friday, with the precious metal hitting record highs…
Read More » -
-
-
-
-
-
-
-
Tech
-
Company
CyberArk’s $20 Billion Courtship: Is Palo Alto Buying the Future of Identity?
Palo Alto Networks is reportedly in advanced talks to acquire CyberArk Software in a deal that could exceed $20 billion,…
Read More » -
Company
Microsoft Joins $4 Trillion Club as AI Investments Push Stock to New Heights
Microsoft has officially entered the elite $4 trillion market cap club, becoming only the second publicly traded company to reach…
Read More » -
Company
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion…
Read More »
Biotech
-
Biotech
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the…
Read More » -
Biotech
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
BioNTech’s recent $1.25 billion all-stock acquisition of former rival CureVac marks a definitive shift in strategy—away from COVID-19 vaccine reliance…
Read More » -
Biotech
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
Bristol Myers has inked a transformative partnership for BNT327, a bispecific PD-L1/VEGF-A antibody developed by BioNTech, with a $1.5 billion…
Read More »
Healthcare
-
Company
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion…
Read More » -
Company
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
DexCom has undergone a major strategic reset after a turbulent 2024, and all eyes are now on its bold shift…
Read More » -
Company
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced…
Read More »
-
Cannabis
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants…
Read More » -
-
-
Follow us on Twitter